Prudential Financial
MDGL icon

Prudential Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

Prudential Financial’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Sell
2,682
-4,259
-61% -$2.18M ﹤0.01% 1524
2026
Q1 		$3.63M Buy
6,941
+1,266
+22% +$605K ﹤0.01% 1063
2025
Q4 		$3.3M Sell
5,675
-238
-4% -$122K ﹤0.01% 1077
2025
Q3 		$2.71M Buy
5,913
+783
+15% +$292K ﹤0.01% 1201
2025
Q2 		$1.55M Buy
5,130
+453
+10% +$135K ﹤0.01% 1493
2025
Q1 		$1.55M Buy
4,677
+1,022
+28% +$336K ﹤0.01% 1401
2024
Q4 		$1.13M Buy
3,655
+2,282
+166% +$642K ﹤0.01% 1529
2024
Q3 		$291K Buy
1,373
+51
+4% +$13K ﹤0.01% 2405
2024
Q2 		$370K Buy
1,322
+203
+18% +$48.3K ﹤0.01% 2292
2024
Q1 		$299K Sell
1,119
-1
-0.1% -$236 ﹤0.01% 2339
2023
Q4 		$259K Buy
+1,120
New +$196K ﹤0.01% 2366
2023
Q3 		– Sell
-1,039
Closed -$240K – 2660
2023
Q2 		$240K Sell
1,039
-5,008
-83% -$1.36M ﹤0.01% 2375
2023
Q1 		$1.46M Sell
6,047
-7,047
-54% -$1.92M ﹤0.01% 1528
2022
Q4 		$3.8M Sell
13,094
-7,755
-37% -$758K 0.01% 988
2022
Q3 		$1.35M Buy
20,849
+50
+0.2% +$3.47K ﹤0.01% 1579
2022
Q2 		$1.49M Buy
+20,799
New +$1.53M ﹤0.01% 1572
2020
Q3 		– Sell
-10,894
Closed -$1.23M – 2456
2020
Q2 		$1.23M Buy
10,894
+20
+0.2% +$1.97K ﹤0.01% 1552
2020
Q1 		$726K Sell
10,874
-76
-0.7% -$6.33K ﹤0.01% 1801
2019
Q4 		$997K Buy
+10,950
New +$1.06M ﹤0.01% 1857
2018
Q4 		– Sell
-1,040
Closed -$223K – 2422
2018
Q3 		$223K Buy
1,040
+210
+25% +$52.7K ﹤0.01% 2304
2018
Q2 		$232K Buy
+830
New +$146K ﹤0.01% 2293

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Prudential Financial's MDGL Position: Q2 2026 in Review

Prudential Financial reduced its Madrigal Pharmaceuticals (MDGL) stake by 61% in Q2 2026, selling an estimated $2.18M and leaving 2,682 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1524.

Prudential Financial first reported a position in MDGL in Q2 2018 and has held it in 21 quarters since. The position peaked at $3.8M in Q4 2022. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Prudential Financial held 2,682 shares of Madrigal Pharmaceuticals worth $1.44M as of Q2 2026.
  • Prudential Financial sold 4,259 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $2.18M.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1524 holding.
  • Prudential Financial first reported a position in Madrigal Pharmaceuticals in Q2 2018 and has held it in 21 quarters since.
  • Prudential Financial's Madrigal Pharmaceuticals position peaked at $3.8M in Q4 2022.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.